Search Results for: NCM-MCI-6.5 Tests 🍟 NCM-MCI-6.5 Online Test 🍰 NCM-MCI-6.5 Demotesten 📔 Suchen Sie jetzt auf ▶ www.itzert.com ◀ nach ▛ NCM-MCI-6.5 ▟ und laden Sie es kostenlos herunter 😭NCM-MCI-6.5 Zertifizierungsfragen
Activity of MK-3118, a New Oral Glucan Synthase Inhibitor, Tested Against Aspergillus spp. using Two Reference Broth Microdilution Methods
Activity of MK-3118, a New Oral Glucan Synthase Inhibitor, Tested Against Aspergillus spp. using Two Reference Broth Microdilution Methods, Lead author: Castanheira M, presented at 52nd annual Interscience Conference of…
In vitro antimicrobial activity of AZD2563, a novel oxazolidinone, tested against Staphylococcus aureus and coagulase-negative staphylococci
In vitro antimicrobial activity of AZD2563, a novel oxazolidinone, tested against Staphylococcus aureus and coagulase-negative staphylococci, presented at 41st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December, 2001,…
Antimicrobial Activity and Spectrum of PPI-0903 (TAK-599), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains
Antimicrobial Activity and Spectrum of PPI-0903 (TAK-599), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains, Lead author: Sader HS, presented at 44th annual Interscience Conference of Antimicrobial…
Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006)
Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Turnidge JD, presented…
Antimicrobial susceptibility of daptomycin and comparator agents tested against bloodstream isolates of Staphylococcus aureus: analysis of a 5-year trend in European medical centres (2005-2009)
Antimicrobial susceptibility of daptomycin and comparator agents tested against bloodstream isolates of Staphylococcus aureus: analysis of a 5-year trend in European medical centres (2005-2009), Lead author: Biedenbach DJ, presented at…
New CLSI Clinical Breakpoints and Epidemiological Cutoff Values Applied to Characterize Resistance in the SENTRY Antifungal Surveillance Program (2010-2011)
New CLSI Clinical Breakpoints and Epidemiological Cutoff Values Applied to Characterize Resistance in the SENTRY Antifungal Surveillance Program (2010-2011), Lead author: Castanheira M, presented at 52nd annual Interscience Conference of…
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual Gram-positive species tested against unusual Gram- positive species
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual Gram-positive species tested against unusual Gram- positive species, presented at 41st annual Interscience Conference of Antimicrobial Agents and Chemotherapy…
10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006)
10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 47th annual Interscience…
Eight-year (2002-2009) summary of the Zyvox Annual Appraisal of Potency and Spectrum Programme in European countries
…and Spectrum Programme in European countries, Lead author: Ross JE, presented at 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10 – 13, 2010, Vienna, Austria…
In vitro activity of a carbapenem and novel beta-lactamase (BL) inhibitor (I) combination (RPX2003/RPX7009) tested against contemporary populations of Gram-negative organisms
In vitro activity of a carbapenem and novel beta-lactamase (BL) inhibitor (I) combination (RPX2003/RPX7009) tested against contemporary populations of Gram-negative organisms, Lead author: Castanheira M, presented at ID Week, October…